We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.02%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$483M
AUM Growth
+$12.7M
(+2.7%)
Cap. Flow
-$7.77M
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
17.02%
Holding
376
New
4
Increased
1
Reduced
1
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$404K |
| 2 |
Rigel Pharmaceuticals
RIGL
|
+$287K |
| 3 |
Dell
DELL
|
+$271K |
| 4 |
CVG
Convergys
CVG
|
+$213K |
| 5 |
ManpowerGroup
MAN
|
+$207K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$1.69M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$1.36M |
| 3 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
+$1.33M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
+$1.21M |
| 5 |
Alaska Air
ALK
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 14.81% |
| 3 | Healthcare | 13.75% |
| 4 | Industrials | 11.98% |
| 5 | Consumer Staples | 9.64% |
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q3 2016 Portfolio in Review
As of Q3 2016, NJ State Employees Deferred Compensation Plan held 376 positions worth $483M, up 2.7% from $471M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Trading was light in Q3 2016: portfolio turnover was 3.7%. NJ State Employees Deferred Compensation Plan opened 4 new positions and exited 10, leaving the 376-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- NJ State Employees Deferred Compensation Plan's largest Q3 2016 buy was St Jude Medical: 5,000 shares worth $399K.
- NJ State Employees Deferred Compensation Plan added most to Rigel Pharmaceuticals in Q3 2016, an estimated $287K increase.
- NJ State Employees Deferred Compensation Plan's biggest Q3 2016 reduction was Sio Gene Therapies Inc. Common Stock, cutting an estimated $450K.
- NJ State Employees Deferred Compensation Plan fully exited Biogen in Q3 2016, selling an estimated $1.69M.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 17% of its $483M portfolio in Q3 2016.
- NJ State Employees Deferred Compensation Plan opened 4 new positions and closed 10 in Q3 2016.
- NJ State Employees Deferred Compensation Plan's portfolio value rose 2.7% quarter-over-quarter to $483M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2016, filed 21 Oct 2016.